151 related articles for article (PubMed ID: 8098017)
21. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
Lee FY; Sciandra J; Siemann DW
Biochem Pharmacol; 1989 Nov; 38(21):3697-705. PubMed ID: 2574574
[TBL] [Abstract][Full Text] [Related]
22. Anomalous expression of P-glycoprotein in highly drug-resistant human KB cells.
Dolci ED; Abramson R; Xuan Y; Siegfried J; Yuenger KA; Yassa DS; Tritton TR
Int J Cancer; 1993 May; 54(2):302-8. PubMed ID: 8098016
[TBL] [Abstract][Full Text] [Related]
23. Chemoresistance to doxorubicin and cisplatin in a murine cell line. Analysis of P-glycoprotein, topoisomerase II activity, glutathione and related enzymes.
Mestdagh N; Pommery N; Saucier JM; Hecquet B; Fournier C; Slomianny C; Teissier E; Hénichart JP
Anticancer Res; 1994; 14(3A):869-74. PubMed ID: 7915509
[TBL] [Abstract][Full Text] [Related]
24. P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell lines.
Huet S; Schott B; Robert J
Br J Cancer; 1992 Apr; 65(4):538-44. PubMed ID: 1348623
[TBL] [Abstract][Full Text] [Related]
25. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
Schneider E; Horton JK; Yang CH; Nakagawa M; Cowan KH
Cancer Res; 1994 Jan; 54(1):152-8. PubMed ID: 7903202
[TBL] [Abstract][Full Text] [Related]
26. Sulfinosine enhances doxorubicin efficacy through synergism and by reversing multidrug resistance in the human non-small cell lung carcinoma cell line (NCI-H460/R).
Pesić M; Andjelković T; Banković J; Marković ID; Rakić L; Ruzdijić S
Invest New Drugs; 2009 Apr; 27(2):99-110. PubMed ID: 18493718
[TBL] [Abstract][Full Text] [Related]
27. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
[TBL] [Abstract][Full Text] [Related]
28. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
Cole SP; Downes HF; Mirski SE; Clements DJ
Mol Pharmacol; 1990 Feb; 37(2):192-7. PubMed ID: 1968221
[TBL] [Abstract][Full Text] [Related]
29. HT1080/DR4: a P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase II.
Zwelling LA; Slovak ML; Doroshow JH; Hinds M; Chan D; Parker E; Mayes J; Sie KL; Meltzer PS; Trent JM
J Natl Cancer Inst; 1990 Oct; 82(19):1553-61. PubMed ID: 1976136
[TBL] [Abstract][Full Text] [Related]
30. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells.
Chiang CD; Song EJ; Yang VC; Chao CC
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):759-64. PubMed ID: 7914401
[TBL] [Abstract][Full Text] [Related]
31. Determinants of response to the DNA topoisomerase II inhibitors doxorubicin and etoposide in human lung cancer cell lines.
Kasahara K; Fujiwara Y; Sugimoto Y; Nishio K; Tamura T; Matsuda T; Saijo N
J Natl Cancer Inst; 1992 Jan; 84(2):113-8. PubMed ID: 1310509
[TBL] [Abstract][Full Text] [Related]
32. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
[TBL] [Abstract][Full Text] [Related]
33. Biochemical and pharmacological characterization of MCF-7 drug-sensitive and AdrR multidrug-resistant human breast tumor xenografts in athymic nude mice.
Mimnaugh EG; Fairchild CR; Fruehauf JP; Sinha BK
Biochem Pharmacol; 1991 Jul; 42(2):391-402. PubMed ID: 1677569
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.
Withoff S; de Vries EG; Keith WN; Nienhuis EF; van der Graaf WT; Uges DR; Mulder NH
Br J Cancer; 1996 Dec; 74(12):1869-76. PubMed ID: 8980384
[TBL] [Abstract][Full Text] [Related]
35. Differential over-expression of mdr1 genes in multidrug-resistant rat glioblastoma cell lines selected with doxorubicin or vincristine.
Schott B; Bennis S; Pourquier P; Ries C; Londos-Gagliardi D; Robert J
Int J Cancer; 1993 Aug; 55(1):115-21. PubMed ID: 8102127
[TBL] [Abstract][Full Text] [Related]
36. Drug resistance in cultured rat liver epithelial cells spontaneously and chemically transformed.
Woo A; Tsao MS; Batist G
Carcinogenesis; 1992 Sep; 13(9):1675-7. PubMed ID: 1382881
[TBL] [Abstract][Full Text] [Related]
37. Anti-tumour activities of a new benzo[c]phenanthridine agent, 2,3-(methylenedioxy)-5-methyl-7-hydroxy-8-methoxybenzo[c]phena nthridini um hydrogensulphate dihydrate (NK109), against several drug-resistant human tumour cell lines.
Kanzawa F; Nishio K; Ishida T; Fukuda M; Kurokawa H; Fukumoto H; Nomoto Y; Fukuoka K; Bojanowski K; Saijo N
Br J Cancer; 1997; 76(5):571-81. PubMed ID: 9303354
[TBL] [Abstract][Full Text] [Related]
38. Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes.
Thierry AR; Vigé D; Coughlin SS; Belli JA; Dritschilo A; Rahman A
FASEB J; 1993 Apr; 7(6):572-9. PubMed ID: 8097173
[TBL] [Abstract][Full Text] [Related]
39. Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase.
Lefevre D; Riou JF; Ahomadegbe JC; Zhou DY; Benard J; Riou G
Biochem Pharmacol; 1991 Jun; 41(12):1967-79. PubMed ID: 1645555
[TBL] [Abstract][Full Text] [Related]
40. Reversal of multidrug resistance in HL-60 cells by verapamil and liposome-encapsulated doxorubicin.
Sadasivan R; Morgan R; Fabian C; Stephens R
Cancer Lett; 1991 May; 57(2):165-71. PubMed ID: 1673873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]